16 juin
17:30 | Virtual

The FARES-II trial: Is it time to replace FP with PCC as first-line therapy for coagulopathic bleeding in cardiac surgery? - Cloned

Join the next Breakthroughs in blood: Advancements into action webinar as Dr. Keyvan Karkouti discusses Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery: The FARES-II Multicenter Randomized Clinical Trial published in JAMA in March 2025. The webinar will
Transfusion

9 juin
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

19 mai
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

12 mai
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

28 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

14 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

7 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

15 avr
12:00 | Virtual

Blood - from splatter to a hemorrhage - Cloned

CSTM Virtual Education Days offer short, 2-3 hour, themed education sessions, with an opportunity to directly connect with the experts via a live Q&A. The Canadian Society for Transfusion Medicine (CSTM) is excited to host it’s 2023 fall education day on November 1, 2023 and it’s all about blood -
Transfusion

20 Aoû
12:00 | Virtual

A focus on the design, conduct, advantages and disadvantages of adaptive platform trials - Cloned - Cloned - Cloned - Cloned - Cloned

The Canadian Transfusion Trials Group (CTTG) is a pioneering national initiative designed to promote collaboration and excellence in Transfusion Medicine research. CTTG, led by co-directors Drs. Donald Arnold and Jeannie Callum, represents a paradigm shift in transfusion medicine research. CTTG
Transfusion

16 Juil
12:00 | Virtual

A focus on the design, conduct, advantages and disadvantages of adaptive platform trials - Cloned - Cloned - Cloned - Cloned

The Canadian Transfusion Trials Group (CTTG) is a pioneering national initiative designed to promote collaboration and excellence in Transfusion Medicine research. CTTG, led by co-directors Drs. Donald Arnold and Jeannie Callum, represents a paradigm shift in transfusion medicine research. CTTG
Transfusion
Subscribe to